Michael Houghton

Michael Houghton, a distinguished British scientist, has made monumental contributions to the field of virology. Born in 1949, he is renowned for his pivotal role in the co-discovery of the Hepatitis C virus in 1989, alongside colleagues Qui-Lim Choo, George Kuo, and Daniel W. Bradley. This groundbreaking discovery has significantly transformed blood safety, reducing the risk of acquiring Hepatitis C through transfusions from one in three to approximately one in two million.

In addition to his work on Hepatitis C, Houghton co-discovered the Hepatitis D genome in 1986, further solidifying his reputation as a leading figure in microbiology and biochemistry. His research has had a profound impact, with antibody testing estimated to prevent at least forty thousand new infections annually in the United States alone, and countless more worldwide.

Currently, Houghton holds the prestigious position of Canada Excellence Research Chair in Virology and serves as the Li Ka Shing Professor of Virology at the University of Alberta. He is also the director of the Li Ka Shing Applied Virology Institute, where he continues to advance the field of virology through innovative research.

In recognition of his exceptional contributions to medicine, Houghton was awarded the Nobel Prize in Physiology or Medicine in 2020, sharing this honor with fellow scientists Harvey J. Alter and Charles M. Rice. His work not only exemplifies scientific excellence but also highlights the importance of research in improving public health.